It should be emphasized that SOX7 re-expression rescued both the SHP2-inefficiency-induced endothelial dysfunction in vitro and SHP2-deletion-induced impairment of tumor angiogenesis in vivo, demonstrating the unique and critical role of this proangiogenic factor in mediating the regulation of tumor angiogenesis by SHP2. This evidence concerns the gene PTPN11 and neoplasm.